Soleno Therapeutics Inc. buy Wells Fargo & Company
Start price
20.08.25
/
50%
€57.65
Target price
20.08.26
€105.76
Performance (%)
-11.97%
Price
03.10.25
€48.38
Summary
This prediction is currently active. The prediction for Soleno Therapeutics Inc. disappoints with a performance of -11.97%. This prediction currently runs until 20.08.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Soleno Therapeutics Inc. | -8.023% | -8.023% |
iShares Core DAX® | 2.709% | 3.467% |
iShares Nasdaq 100 | 0.867% | 5.198% |
iShares Nikkei 225® | 3.135% | 9.423% |
iShares S&P 500 | 0.886% | 3.586% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Soleno Therapeutics Inc. diskutieren
Soleno Therapeutics (NASDAQ:SLNO) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $123.00 price target on the stock.
Ratings data for SLNO provided by MarketBeat